Yes, mild to moderate nausea affects 25 to 40 percent of patients during the first few days to one week of treatment
More than 80 peptide-based drugs have been approved worldwide for a range of conditions, reflecting how important peptide signaling is in medicine
False advertising: Be cautious of pharmacies that claim compounded semaglutide is a generic version of Ozempic or Wegovy
discuss with doctor if severe Week 1316: Maintenance Dose (9mg or continuing to 12mg) For 9mg group (maintenance): Side effects stabilize Nausea decreases (2025% still experiencing) Dysesthesia: 8.8% incidence (mild) Body adapting well For 12mg group (final increase): GI effects may temporarily worsen (4045% nausea) Dysesthesia peaks (20.9% incidence) This is the "make or break" dose highest efficacy, highest side effects Duration: 12 weeks adjustment period Week 17+: Long-Term Maintenance Side effects: Nausea: Decreases to 1525% (down from 4045%) Diarrhea: Improves to 1020% Dysesthesia: Stable at 8.820.9% (doesn't worsen) Most people feel "normal" except for reduced appetite Key point: Side effects are WORST during dose escalation (weeks 116)
Your care is guided, safe, and transparent
If your reactions are not dangerous but continue to bother you, your prescriber may adjust your dose or suggest switching medications
